JH
Insider
James Healy
DirectorJames Healy (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in BioAge Labs, Inc. (BIOA). Across 1 priced purchase filing, the average 21-session return was +24.7% from execution and +24.7% from disclosure (delay-adjusted; derived). The largest single filing was $12.0M of BIOA (666,665 sh across 5 lots, as filed), executed Sep 27 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+24.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+24.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 27 2024
Filed Sep 27 2024
Median ADV $8.8M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
BIOA
BioAge Labs, Inc.
BIOA · 1 buy · 0 sells
1 filing
Recent filings
BIOAPURCHASE
BioAge Labs, Inc.
View filing →
$12.0M666,665 sh across 5 lots
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET